JIP3 knockout protects mice against high fat diet-induced liver injury

Area of Science:

• Biochemistry
• Molecular Biology
• Metabolic Diseases

Background:

• Nonalcoholic fatty liver disease (NAFLD) involves complex pathways influenced by high-fat diets (HFD).
• JNK-interacting protein 3 (JIP3), also known as JSAP-1, is implicated in various cellular signaling pathways.
• Understanding JIP3's role in metabolic pathologies is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role of JIP3 in the development of obesity-related pathologies, specifically in the context of NAFLD.
• To determine the impact of JIP3 deficiency on metabolic dysregulation induced by HFD.

Main Methods:

• Wild-type (WT) and JIP3-knockout (JIP3^-/-) mice were fed either a standard chow or HFD.
• Key metabolic, oxidative stress, and inflammatory markers were assessed in liver tissues.
• Signaling pathway components including lipogenesis, PPARs, Nrf-2, TLRs, NF-κB, and JNK were analyzed.

Main Results:

• HFD increased hepatic JIP3 expression in WT mice.
• JIP3^-/- mice showed reduced weight gain, hepatic steatosis, insulin resistance, and lipid accumulation compared to WT mice on HFD.
• JIP3 deficiency significantly decreased hepatic oxidative stress markers (ROS, MDA, iNOS) and inflammatory mediators (TLRs, NF-κB, JNK), while increasing antioxidant capacity (SOD, TAC).
• Lipogenesis pathways were inhibited, and PPARα/γ signaling was upregulated in JIP3^-/- mice.

Conclusions:

• JIP3 absence protects against HFD-induced metabolic dysfunction, including hepatic steatosis, insulin resistance, oxidative stress, and inflammation.
• JIP3 plays a significant role in mediating the pathological effects of HFD.
• Targeting JIP3 presents a promising therapeutic strategy for managing NAFLD.